Biofilm bacteria: formation and comparative susceptibility to antibiotics.

535 indexed citations

Abstract

loading...

About

This paper, published in 2002, received 535 indexed citations. Written by Merle S. Olson, Howard Ceri, Douglas W. Morck, André G. Buret and R. R. Read covering the research area of Molecular Biology, Microbiology and Clinical Biochemistry. It is primarily cited by scholars working on Molecular Biology (256 citations), Microbiology (109 citations) and Infectious Diseases (89 citations). Published in PubMed.

In The Last Decade

doi.org/w74831343 →

Countries where authors are citing Biofilm bacteria: formation and comparative susceptibility to antibiotics.

Specialization
Citations

This map shows the geographic impact of Biofilm bacteria: formation and comparative susceptibility to antibiotics.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biofilm bacteria: formation and comparative susceptibility to antibiotics. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biofilm bacteria: formation and comparative susceptibility to antibiotics. more than expected).

Fields of papers citing Biofilm bacteria: formation and comparative susceptibility to antibiotics.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Biofilm bacteria: formation and comparative susceptibility to antibiotics.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Biofilm bacteria: formation and comparative susceptibility to antibiotics..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w74831343.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Electroencephalogram signatures of loss and recovery of consciousness from propofol Breakdown of academic impact, for the paper Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial Breakdown of academic impact, for the paper Phase II Trial of Sorafenib in Advanced Thyroid Cancer Breakdown of academic impact, for the paper Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiae Breakdown of academic impact, for the paper Gut microbiota induce IGF-1 and promote bone formation and growth Breakdown of academic impact, for the paper Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring Breakdown of academic impact, for the paper RNA Polymerase IV Directs Silencing of Endogenous DNA Breakdown of academic impact, for the paper Offspring from Oocytes Derived from in Vitro Primordial Germ Cell–like Cells in Mice Breakdown of academic impact, for the paper Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043) Breakdown of academic impact, for the paper Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Rankless by CCL
2026